{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T16:24:44Z","timestamp":1793982284538,"version":"4.8.0"},"reference-count":23,"publisher":"American Society of Hematology","issue":"20","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,11,18]]},"abstract":"<jats:p>Cold antibody-mediated autoimmune hemolytic anemia (cAIHA) is a rare disease, usually related to an underlying indolent clonal B-cell lymphoproliferative disorder. Jalink and colleagues describe an international retrospective analysis of Bruton tyrosine kinase (BTK) inhibition in patients with cAIHA. The data indicate a rapid and notable improvement in both the hemolytic anemia as well as acrocyanosis, suggesting that this may be an effective approach, regardless of underlying pathology or MYD88 mutational status.<\/jats:p>","DOI":"10.1182\/blood.2021012039","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T18:04:53Z","timestamp":1626977093000},"page":"2002-2005","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":59,"title":["Effect of ibrutinib treatment on hemolytic anemia and acrocyanosis in cold agglutinin disease\/cold agglutinin syndrome"],"prefix":"10.1182","volume":"138","author":[{"given":"Marit","family":"Jalink","sequence":"first","affiliation":[{"name":"Center for Clinical Transfusion Research, Sanquin Research, Amsterdam, The Netherlands;"},{"name":"Department of Hematology, Amsterdam University Medical Center (UMC), University of Amsterdam, Amsterdam, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3425-4653","authenticated-orcid":false,"given":"Sigbj\u00f8rn","family":"Berentsen","sequence":"additional","affiliation":[{"name":"Department of Research and Innovation, Haugesund Hospital, Haugesund, Norway;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9490-7532","authenticated-orcid":false,"given":"Jorge J.","family":"Castillo","sequence":"additional","affiliation":[{"name":"Bing Center for Waldenstrom's Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6393-6154","authenticated-orcid":false,"given":"Steven P.","family":"Treon","sequence":"additional","affiliation":[{"name":"Bing Center for Waldenstrom's Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjan","family":"Cruijsen","sequence":"additional","affiliation":[{"name":"Department of Hematology, Catharina Hospital, Eindhoven, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0857-8379","authenticated-orcid":false,"given":"Bruno","family":"Fattizzo","sequence":"additional","affiliation":[{"name":"Hematology Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico and University of Milan, Milano, Italy;"},{"name":"Department of Oncology and Oncohematology, University of Milan, Milan, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramona","family":"Cassin","sequence":"additional","affiliation":[{"name":"Hematology Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico and University of Milan, Milano, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Despina","family":"Fotiou","sequence":"additional","affiliation":[{"name":"Department of Clinical Therapeutics, National and Kapodistrian University of Athens School of Medicine, Athens, Greece;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8191-5832","authenticated-orcid":false,"given":"Efstathios","family":"Kastritis","sequence":"additional","affiliation":[{"name":"Department of Clinical Therapeutics, National and Kapodistrian University of Athens School of Medicine, Athens, Greece;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masja","family":"De Haas","sequence":"additional","affiliation":[{"name":"Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands;"},{"name":"Department of Immunohematology Diagnostics, Sanquin, Amsterdam, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liesbeth E. M.","family":"Oosten","sequence":"additional","affiliation":[{"name":"Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8905-0220","authenticated-orcid":false,"given":"Henrik","family":"Frederiksen","sequence":"additional","affiliation":[{"name":"Department of Hematology, Odense University Hospital, Odense, Denmark;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4415-2906","authenticated-orcid":false,"given":"Andrea","family":"Patriarca","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Translational Medicine, Universit\u00e0 del Piemonte Orientale, Novara, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley","family":"D'Sa","sequence":"additional","affiliation":[{"name":"UCLH Centre for Waldenstr\u00f6m\u2019s Macroglobulinemia and Related Conditions, University College London Hospitals NHS Foundation Trust, London, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3229-9556","authenticated-orcid":false,"given":"Josephine M.I.","family":"Vos","sequence":"additional","affiliation":[{"name":"Department of Hematology, Amsterdam University Medical Center (UMC), University of Amsterdam, Amsterdam, The Netherlands;"},{"name":"Department of Immunohematology Diagnostics, Sanquin, Amsterdam, The Netherlands;"},{"name":"Lymphoma and Myeloma Center Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"4","key":"2021112418411746600_B1","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1182\/blood.2020005674","article-title":"Cold agglutinin disease revisited: a multinational, observational study of 232 patients","volume":"136","author":"Berentsen","year":"2020","journal-title":"Blood."},{"issue":"7","key":"2021112418411746600_B2","doi-asserted-by":"crossref","first-page":"E262","DOI":"10.1002\/ajh.26196","article-title":"Seasonal variation in the incidence of cold agglutinin disease in Norway, Denmark, and Italy","volume":"96","author":"Hansen","year":"2021","journal-title":"Am J Hematol."},{"issue":"3","key":"2021112418411746600_B3","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3324\/haematol.2013.091702","article-title":"Primary cold agglutinin-associated lymphoproliferative disease: a B-cell lymphoma of the bone marrow distinct from lymphoplasmacytic lymphoma","volume":"99","author":"Randen","year":"2014","journal-title":"Haematologica."},{"key":"2021112418411746600_B4","doi-asserted-by":"crossref","first-page":"100648","DOI":"10.1016\/j.blre.2019.100648","article-title":"Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting","volume":"41","author":"J\u00e4ger","year":"2020","journal-title":"Blood Rev."},{"issue":"10","key":"2021112418411746600_B5","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1182\/blood.2019003809","article-title":"How I treat cold agglutinin disease","volume":"137","author":"Berentsen","year":"2021","journal-title":"Blood."},{"issue":"3","key":"2021112418411746600_B6","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.blre.2012.01.002","article-title":"Diagnosis and treatment of cold agglutinin mediated autoimmune hemolytic anemia","volume":"26","author":"Berentsen","year":"2012","journal-title":"Blood Rev."},{"issue":"4","key":"2021112418411746600_B7","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1182\/blood-2017-04-778175","article-title":"Bendamustine plus rituximab for chronic cold agglutinin disease: results of a Nordic prospective multicenter trial","volume":"130","author":"Berentsen","year":"2017","journal-title":"Blood."},{"issue":"17","key":"2021112418411746600_B8","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1182\/blood-2010-06-288647","article-title":"High response rate and durable remissions following fludarabine and rituximab combination therapy for chronic cold agglutinin disease","volume":"116","author":"Berentsen","year":"2010","journal-title":"Blood."},{"issue":"9","key":"2021112418411746600_B9","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1182\/blood-2018-06-856930","article-title":"Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: a first-in-human trial","volume":"133","author":"J\u00e4ger","year":"2019","journal-title":"Blood."},{"issue":"6","key":"2021112418411746600_B10","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1182\/bloodadvances.2019001321","article-title":"Inhibition of complement C1s in patients with cold agglutinin disease: lessons learned from a named patient program","volume":"4","author":"Gelbenegger","year":"2020","journal-title":"Blood Adv."},{"issue":"14","key":"2021112418411746600_B11","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1056\/NEJMoa2027760","article-title":"Sutimlimab in cold agglutinin disease","volume":"384","author":"R\u00f6th","year":"2021","journal-title":"N Engl J Med."},{"issue":"1","key":"2021112418411746600_B12","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3816\/CLM.2009.n.030","article-title":"Cold agglutinin-mediated autoimmune hemolytic anemia in Waldenstr\u00f6m\u2019s macroglobulinemia","volume":"9","author":"Berentsen","year":"2009","journal-title":"Clin Lymphoma Myeloma."},{"issue":"11","key":"2021112418411746600_B13","doi-asserted-by":"crossref","first-page":"e827","DOI":"10.1016\/S2352-3026(20)30224-6","article-title":"Consensus treatment recommendations from the tenth International Workshop for Waldenstr\u00f6m Macroglobulinaemia","volume":"7","author":"Castillo","year":"2020","journal-title":"Lancet Haematol."},{"issue":"6","key":"2021112418411746600_B14","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMc1506192","article-title":"MYD88 mutations and response to ibrutinib in Waldenstr\u00f6m\u2019s macroglobulinemia","volume":"373","author":"Treon","year":"2015","journal-title":"N Engl J Med."},{"issue":"15","key":"2021112418411746600_B15","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1056\/NEJMoa1501548","article-title":"Ibrutinib in previously treated Waldenstr\u00f6m\u2019s macroglobulinemia","volume":"372","author":"Treon","year":"2015","journal-title":"N Engl J Med."},{"issue":"25","key":"2021112418411746600_B16","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1182\/blood.2020008201","article-title":"Preexisting and treatment-emergent autoimmune cytopenias in patients with CLL treated with targeted drugs","volume":"137","author":"Vitale","year":"2021","journal-title":"Blood."},{"key":"2021112418411746600_B17","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.3389\/fonc.2019.01435","article-title":"Autoimmune cytopenias in chronic lymphocytic leukemia: focus on molecular aspects","volume":"9","author":"Fattizzo","year":"2020","journal-title":"Front Oncol."},{"key":"2021112418411746600_B18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.leukres.2016.09.002","article-title":"Autoimmune hemolytic anemia (AIHA) associated with chronic lymphocytic leukemia in the current era of targeted therapy","volume":"50","author":"Molica","year":"2016","journal-title":"Leuk Res."},{"issue":"3","key":"2021112418411746600_B19","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/bjh.15545","article-title":"Autoimmune cytopenias in patients with chronic lymphocytic leukaemia treated with ibrutinib in routine clinical practice at an academic medical centre","volume":"183","author":"Hampel","year":"2018","journal-title":"Br J Haematol."},{"issue":"2","key":"2021112418411746600_B20","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/leu.2015.273","article-title":"Incidence and description of autoimmune cytopenias during treatment with ibrutinib for chronic lymphocytic leukemia","volume":"30","author":"Rogers","year":"2016","journal-title":"Leukemia."},{"issue":"5","key":"2021112418411746600_B21","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/bjh.13328","article-title":"Ibrutinib is an effective treatment of autoimmune haemolytic anaemia in chronic lymphocytic leukaemia","volume":"170","author":"Manda","year":"2015","journal-title":"Br J Haematol."},{"issue":"1","key":"2021112418411746600_B22","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1365-2141.2011.08707.x","article-title":"Autoimmune cytopenia in chronic lymphocytic leukaemia: diagnosis and treatment","volume":"154","author":"Hodgson","year":"2011","journal-title":"Br J Haematol."},{"issue":"4","key":"2021112418411746600_B23","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1182\/blood-2017-06-788463","article-title":"Hot therapy for cold agglutinin disease","volume":"130","author":"Jaeger","year":"2017","journal-title":"Blood."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/138\/20\/2002\/1847103\/bloodbld2021012039.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/138\/20\/2002\/1847103\/bloodbld2021012039.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T18:41:33Z","timestamp":1637779293000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/138\/20\/2002\/476451\/Effect-of-ibrutinib-treatment-on-hemolytic-anemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,18]]},"references-count":23,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2021,11,18]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2021012039","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,18]]}}}